Common TitleNIAID Retreatment of Sofosbuvir Failures (Genotype 1)
Official Title Re-Treatment of Chronic Hepatitis C Virus Genotype 1 Infection after Relapse: an Open-Label Pilot Study.
Phase Phase II
ClinicalTrials.gov NCT01805882
Treatments
Ledipasvir-Sofosbuvir

Ledipasvir-Sofosbuvir
Tradename:HarvoniOther Names:LDV-SOFClass:FDA-ApprovedFunding
Non-IndustryNational Institute of Allergy and Infectious Diseases (NIAID)